Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 6, 2013

View Archived Issues

Researchers at AbbVie synthesize new compounds for RSV infection

Tris Pharma and FSC Laboratories sign commercialization agreement for Karbinal ER

Comfrey root extract with methyl nicotinate effective for low back pain

Crinetics Pharmaceuticals receives grant to develop drugs for pituitary tumors

ThromboGenics and Bicycle Therapeutics to collaborate on bicyclic peptide inhibitors

Novel genetic locus associated with a childhood gastrointestinal disease identified

Proof-of-concept for gene therapy-mediated retinal rescue using a novel transgenic mouse model

Gene-centric association study of complications associated with sickle cell disease

XBiotech begins preclinical study of antibody therapy for MRSA

First milestone reached within Karo Bio and Pfizer's RORgamma collaboration

KemPharm expands pain therapy pipeline with KP-606

FDA accepts complete response submission to Aveed NDA

Bayer HealthCare applies for approval of regorafenib for GIST in Europe

Tablet formulation of Boldocynara shows efficacy in patients with functional digestive disorders

RQx Pharmaceuticals patents new signal peptidase inhibitors

New York University and USC patent novel agents for cancer and other disorders

New kinase inhibitors synthesized at Merck KGaA

Extract from S. scardica shows promise for Alzheimer's disease treatment

Otsuka Pharmaceutical to acquire Astex Pharmaceuticals

Viamet begins phase II studies of antifungal VT-1161

Medivir and Daewoong discontinue development of hepatitis B compound

Novel vaccines for tuberculosis disclosed

Almac Discovery and Queen's University Belfast form new partnership

Plasma uridine as a biomarker of ornithine transcarbamylase deficiency

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...